N-(3-iodophenyl)trozamicol (IPHT) and related inhibitors of vesicular acetylcholine transport: Synthesis and preliminary biological characterization

Nuclear Medicine and Biology

Volumn 26, Issue 6, 1999, Pages 609-617

  Khare, A B ^a   Langason, R B ^a   Parsons, S M ^b   Mach, R H ^c   Efange, S M N ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Radioligands; Vesamicol; Vesicular acetylcholine transport

Indexed keywords

N (3 IODOPHENYL)TROZAMICOL; RADIOLIGAND; TRACER; UNCLASSIFIED DRUG; VESAMICOL; VESICULAR ACETYLCHOLINE TRANSPORTER;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PARASYMPATHETIC INNERVATION; RAT; TISSUE DISTRIBUTION;

ACETYLCHOLINE; ANIMALS; BINDING, COMPETITIVE; BRAIN; CARRIER PROTEINS; INDICATORS AND REAGENTS; IODINE RADIOISOTOPES; IODOBENZENES; ISOMERISM; KINETICS; LIGANDS; MALE; MEMBRANE TRANSPORT PROTEINS; MOLECULAR STRUCTURE; PIPERAZINES; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, SIGMA; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 0032830612     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00013-X     Document Type: Article

References (55)

1. Alfonso A., Grundahl K., Duerr J.S., Han H.-P., Rand J.B. The Caenorhabditis elegans unc-17 gene A putative vesicular acetylcholine transporter . Science. 261:1993;617-619.
2. Alfonso A., Grundahl K., McManus J.R., Asbury J.M., Rand J.B. Alternative splicing leads to two cholinergic proteins in Caenorhabditis elegans. J. Mol. Biol. 241:1994;627-630.
3. 3H]-piperidino)cyclohexanol. Proc. Natl. Acad. Sci. USA. 83:1986;2267-2270.
4. Bejanin S., Cervini R., Mallet J., Berrard S. A unique gene organization for two cholinergic markers, choline acetyltransferase and a putative vesicular transporter of acetylcholine. J. Biol. Chem. 269:1994;21944-21947.
5. Brittain R.T., Levy G.P., Tyers M.B. The neuromuscular blocking action of 2-(4-phenylpiperidino)cyclohexanol (AH 5183). Eur. J. Pharmacol. 8:1969;93-99.
6. Coffeen P.R., Efange S.M.N., Haidet G.C., McNite S., Langason R.B., Khare A.B., Pennington J., Lurie K.G. Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand. Nucl. Med. Biol. 23:1996;923-926.
7. 2 dopamine receptors and the regulation of striatal acetylcholine release in vivo. Progr. Brain Res. 98:1993;201-207.
8. Consolo S.P., Girotti P., Zambelli M., Russi G., Benzi M., Bertorelli R. D1 and D2 dopamine receptors and the regulation of striatal acetylcholine release in vivo. Progr. Neurobiol. 98:1993;201-207.
9. Efange S.M.N., Garland E., Staley J.K., Khare A.B., Mash D.C. Vesicular acetylcholine transporter (VAChT) density and Alzheimer's disease. Neurobiol. Aging. 18:1997;407-413.
10. Efange S.M.N., Kamath A.P., Khare A.B., Kung M.P., Mach R.H., Parsons S.M. N-Hydroxyalkyl derivatives of 3-β-phenyltropane and 1-methylspiro[1H-indoline-3,4′-piperidine] Vesamicol analogues with affinity for monoamine transporters and receptors . J. Med. Chem. 40:1997;3905-3914.
11. Efange S.M.N., Khare A.B., Foulon C., Akella S.K., Parsons S.M. Spirovesamicols Conformationally restricted analogs of 2-(4-phenylpiperidino)-cyclohexanol (vesamicol, AH5183) as potential modulators of presynaptic cholinergic function . J. Med Chem. 37:1994;2574-2582.
12. Efange S.M.N., Khare A.B., Parsons S.M., Bau R., Metzenthin T. Nonsymmetrical bipiperidyls as inhibitors of vesicular acetylcholine storage. J. Med. Chem. 36:1993;985-989.
13. Efange S.M.N., Langason R.B., Khare A.B. Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding. J. Nucl. Med. 37:1996;1192-1197.
14. 2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat Possible implications for Parkinson's disease . Life Sci. 58:1996;1367-1375.
15. 18F]FBT) Molecular decomposition-reconstitution approach to vesamicol receptor radioligands . Appl. Radiat. Isot. 45:1994;465-472.
16. Efange S.M.N., Mach R.H., Smith C.R., Khare A.B., Foulon C., Akella S.K., Childers S.R., Parsons S.M. Vesamicol analogues as sigma ligands Molecular determinants of selectivity at the vesamicol receptor . Biochem. Pharmacol. 49:1995;791-797.
17. Efange S.M.N., Michelson R.H., Dutta A.K., Parsons S.M. Acyclic analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol) Conformationally mobile inhibitors of vesicular acetylcholine transport . J. Med. Chem. 34:1991;2638-2643.
18. 125I]MIBT) Potential radiotracer for mapping central cholinergic innervation . J. Med. Chem. 36:1993;1754-1760.
19. Erickson J.D., Varoqui H., Schafer M.K.-H., Modi W., Diebler M.-F., Weihe E., Rand J., Eiden L.E., Bonner T.I., Usdin T.B. Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J. Biol. Chem. 269:1994;21929-21932.
20. Gilmor M.L., Nash N.R., Roghani A., Edwards R.H., Yi H., Hersch S.M., Levey A.I. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J. Neurosci. 16:1996;2179-2190.
21. 3H]DOPA in various regions of the brain. J. Neurochem. 13:1966;655-669.
22. Ichikawa T., Ajiki K., Matsuura J., Misawa H. Localization of two cholinergic markers, choline acetyltransferase and vesicular acetylcholine transporter in the central nervous system of the rat In situ hybridization histochemistry and immunohistochemistry . J. Chem. Neuroanat. 13:1997;23-39.
23. Ingvar M., Stone-Elander S., Rogers G.A., Johansson B., Eriksson L., Parsons S.M., Widen L. Striatal D2/acetylcholine interactions PET studies of the vesamicol receptor . NeuroReport. 4:1993;1311-1314.
24. Jung Y.-W., Frey K.A., Mulholland G.K., del Rosario R., Sherman P.S., Raffel D.M., van Dort M.E., Kuhl D.E., Gildersleeve D.L., Wieland D.M. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. J. Med. Chem. 39:1996;3331-3342.
25. Jung Y.-W., Gildersleeve D.L., Van Dort M.E., Kuhl D.E., Wieland D.M. Synthesis and in vivo evaluation of radioiodinated (+)-7-iodobenzovesamicol A high affinity ligand for the sigma binding site . J. Labelled Compd. Radiopharm. 35:1994;202-204.
26. Jung Y.-W., Van Dort M.E., Gildersleeve D.L., Wieland D.M. A radiotracer for mapping cholinergic neurons of the brain. J. Med. Chem. 33:1990;2065-2068.
27. Kilbourn M.R., Jung Y.-W., Haka M.S., Gildersleeve D.L., Kuhl D.E., Wieland D.M. Mouse brain distribution of a carbon-11 labeled vesamicol derivative Presynaptic marker of cholinergic neurons . Life Sci. 47:1990;1955-1963.
28. Kitamoto T., Wang W., Salvaterra P.M. Structure and organization of the Drosophila cholinergic locus. J. Biol. Chem. 273:1998;2706-2713.
29. 18F]4-fluorobenzyltrozamicol. In vitro binding studies and positron emission tomography studies in nonhuman primates. Synapse. 25:1997;368-380.
30. Marshall I.G. Studies on the blocking action of 2-(4-phenylpiperidino)cyclohexanol (AH 5183). Br. J. Pharmacol. 38:1970;503-516.
31. Marshall I.G., Parsons S.M. The vesicular acetylcholine transport system. Trends Neurosci. 10:1987;174-177.
32. 18F]Fluorobenzyl-ABV A new potential marker for central cholinergic presynaptic sites . J. Nucl. Med. 32:(Suppl.):1991;994.
33. 18F]fluoroethoxy-benzovesamicol (FEOBV): A new tracer for mapping cholinergic neurons in vivo. Abstracts of the IXth International Symposium on Radiopharmaceutical Chemistry, 487-488.
34. Nacif J.M., Misawa H., Dedman J.R. Molecular characterization of the mouse vesicular acetylcholine transporter gene. NeuroReport. 8:1997;3467-3473.
35. Parsons S.M., Prior C., Marshall I.G. Acetylcholine transport, storage and release. Int. Rev. Neurobiol. 35:1993;279-390.
36. Prior C., Marshall I.G., Parsons S.M. The pharmacology of vesamicol An inhibitor of the vesicular acetylcholine transporter . Gen. Pharmacol. 23:1992;1017-1022.
37. Rogers G.A., Kornreich W.D., Hand K., Parsons S.M. Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants. Mol. Pharmacol. 44:1993;633-641.
38. Rogers G.A., Parsons S.M., Anderson D.C., Nilsson L.M., Bahr B.A., Kornreich W.D., Kaufman R., Jacobs R.S., Kirtman B. Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans- 2-(4-phenylpiperidino)cyclohexanol (vesamicol). J. Med. Chem. 32:1989;1217-1230.
39. 18F-labelled vesamicol derivatives Synthesis and preliminary in vivo small animal positron emission tomography evaluation . Nucl. Med. Biol. 21:1994;219-230.
40. Roghani A., Feldman J., Kohan S.A., Shirzadi A., Gundersen C.B., Brecha N., Edwards R.H. Molecular cloning of a putative vesicular transporter for acetylcholine. Proc. Natl. Acad. Sci. USA. 91:1994;10620-10624.
41. Russell A.F., Greenberg S., Moffatt J.G. Reactions of 2-acyloxyisobutyryl halides with nucleosides. II. Reactions with adenosine. J. Org. Chem. 95:1973;4025-4030.
42. Schafer M.K.-H., Eiden L.E., Weihe E. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter - I. Central nervous system. Neuroscience. 84:1998;331-359.
43. Schafer M.K.-H., Eiden L.E., Weihe E. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter - II. The peripheral nervous system. Neuroscience. 84:1998;361-376.
44. Schafer M.K.-H., Weihe E., Erickson J.D., Eiden L.E. Human and monkey cholinergic neurons visualized in paraffin-embedded tissues by immunoreactivity for VAChT, the vesicular acetylcholine transporter. J. Mol. Neurosci. 6:1995;225-235.
45. Schafer M.K.-H., Weihe E., Varoqui H., Eiden L.E., Erickson J.D. Distribution of the vesicular acetylcholine transporter (VAChT) in the central and peripheral nervous systems of the rat. J. Mol. Neurosci. 5:1994;1-26.
46. Shiba K., Mori H., Ichikawa A., Tonami N. In vitro characterization of radioiodinated (-)-m-iodovesamicol in rat cerebral membranes. Life Sci. 59:1996;1039-1045.
47. Shiba K., Mori H., Matsuda H., Ichikawa A., Tonami N. Radioiodinated (-)-2-[4-(3-iodophenyl)piperidino]cyclohexanol A potential radioligand for mapping presynaptic cholinergic neurons . Nucl. Med. Comm. 17:1996;485-492.
48. Shiba K., Mori H., Matsuda H., Tsuji S., Kuji I., Sumiya H., Kinuya K., Tonami N., Hisada K., Sumiyosi T. Synthesis of radioiodinated analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol) as vesamicol-like agent. Nucl. Med. Biol. 22:1995;205-210.
49. 125I]MIBT in primate brain. Eur. J. Pharmacol. 338:1997;159-169.
50. Stoof J.C., Drukarch B., de Boer P., Westerink B.H.C., Groenewegen H.J. Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience. 47:1992;755-770.
51. Sura T.P., Ramana M.M.V., Kudav N.A. Urea nitrate A reagent for regioselective nitration of aromatic amines . Synthetic Commun. 18:1988;2161-2165.
52. Usdin T.B., Eiden L.E., Bonner T.I., Erickson J.D. Molecular biology of the vesicular acetylcholine transporter. Trends Neurosci. 18:1995;218-224.
53. Varoqui H., Diebler M.-F., Meunier F.-M., Rand J.B., Usdin T.B., Bonner T.I., Eiden L.E., Erickson J.D. Cloning and expression of the vesamicol binding protein from the marine ray Torpedo. Homology with the putative vesicular acetylcholine transporter UNC-17 from Caenorhabditis elegans. FEBS Lett. 342:1994;97-102.
54. Wannan G., Prior C., Marshall I.G. α-Adrenoceptor blocking properties of vesamicol. Eur. J. Pharmacol. 201:1991;29-34.
55. Weihe E., Tao-Cheng J.H., Schafer M.K.-H., Erickson J.D., Eiden L.E. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc. Natl. Acad. Sci. USA. 93:1996;3547-3552.